Laura Attademo

Naples, 80147, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 13, 2025

Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Journal: JCO precision oncology
Published: September 10, 2025

Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group.

Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group.

Journal: Cancers
Published: November 06, 2023

Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas.

Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas.

Journal: Biomedicines
Published: December 13, 2021

BRAF Gene and Melanoma: Back to the Future.

BRAF Gene and Melanoma: Back to the Future.

Journal: International journal of molecular sciences
Published: March 09, 2021

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7).

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7).

Journal: American journal of clinical oncology
Published: February 22, 2021

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.

Journal: Journal of clinical medicine
Published: January 08, 2021

How to Treat Hepatocellular Carcinoma in Elderly Patients.

How to Treat Hepatocellular Carcinoma in Elderly Patients.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2020

From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer.

From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer.

Journal: Immunotherapy
Published: October 13, 2020

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.

Journal: Journal for immunotherapy of cancer
Published: August 08, 2020

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.

Journal: Scientific reports
Published: May 28, 2020

Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy.

Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 01, 2020
Showing 1-12 of 25

Last Updated: 09/26/2026